The application of next generation sequencing (NGS) on breast cancer has been associated with tremendous advances in the understanding of the disease. NGS can assist with screening for familial predisposition and can identify pathogenic sequence variants (mutations) that have an important predictive role in the implementation of targeted therapy.... Read more
The Oncomine Comprehensive Assay Plus (OCAPLUS) is a Next Generation Sequencing (NGS) test that allows for extensive solid tumour genomic profiling based on the analysis of more than 500 genes, including mutations, fusions, and copy number variations (CNVs).... Read more